- This event has passed.
From The Footbridge to Bridge St: understanding the start-up experience
17 May, 2016 @ 12:00 pm - 1:00 pmFree
From The Footbridge To Bridge St: the start-up experience is a free one-hour lunch event at 12 midday on Tuesday May 17 2016 for students with an interest in entrepreneurship.
The event, introduced by The Warren Centre’s Executive Director Ashley Brinson, will feature Dr Ilana Feain, a University of Sydney PhD graduate, describing the life of her early-stage start-up that seeks to build a cancer treatment radiation machine for the developing world; and Dr Alan Taylor, CEO of radiotherapy start-up Clarity Pharmaceutical, which is about to announce results from a major clinical trial.
The speakers will talk about their challenges and exciting experiences along the start-up journey. There will be a Q&A opportunity following the speaker presentations. Pizza will be served as part of the event.
If you are interested in attending this free event, please fill out and submit the form below:
Dr Ilana Feain, Founder and Director, Nano-X
Dr Feain is a start-up entrepreneur building a cancer treatment device for emerging markets. With a patent pending, start-up support from University of Sydney and a newly appointed co-executive, Nano-X is poised to ramp up rapidly.
Dr Feain is in the very early stages of commercialisation spending three days a week at ATP Innovations developing the business and two days at Westmead Hospital performing clinical trials. Dr Feain will share her story from early in the entrepreneurship journey.
Dr Alan Taylor, CEO, Clarity Pharmaceuticals
Clarity Pharmaceuticals is a radiopharmaceutical company focused on the treatment of serious disease. Founded in 2010, Clarity’s technology platform comes from ANSTO and the University of Melbourne. Multiple series of investment funding have advanced Clarity further along the start-up experience. This month the company announced the appointment of Dr Chris Roberts as director (former Cochlear CEO, Chairman of Sirtex, and ResMed VP). In the last few weeks, Clarity was been awarded a Business Growth Grant under the Entrepreneurs’ Programme and a $1 million Accelerating Commercialisation Grant. The company will announce results of a clinical trial data at an upcoming June 2016 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in San Diego, California. Dr Taylor will share his experiences from later stages in the start-up journey.
Image: Clarity Pharmaceuticals technology undergoing clinical trials. Source